drugset

drugset / Trial / NCT00815763

Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke

NCT00815763 ↗

Phase 3 Completed 390 enrolled Xijing Hospital

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this phase 3 study is to validate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.

Timeline

Start: 2006-09
Primary completion: 2008-06
Completion: 2008-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ginsenoside-Rd	Unknown	20 mg	—

Indications